Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - COST OF REVENUE
Cost of Revenue ALNY - Alnylam Pharmaceuticals, Inc.
323 M
LAST VALUE
38.40%
2 YEAR CAGR
66.78%
5 YEAR CAGR
0.00%
10 YEAR CAGR